MSD Looks Ahead For Japan Growth Amid Policy Challenges
This article was originally published in PharmAsia News
Executive Summary
Despite a stream of new launches over the past few years, last year was a “challenging” one for MSD in Japan due mainly to generic competition, but the company expects the new products to help drive growth over the next few years.